← FDA Drug Approvals (Drugs@FDA)

ORPHENADRINE CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2000-02-15

Drug application

FDA Application #

ANDA040327

Application type

Abbreviated New Drug Application (Generic)

Brand name

ORPHENADRINE CITRATE

Generic name

ORPHENADRINE CITRATE

Active ingredients

ORPHENADRINE CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2000-02-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown